Leadership Overview
AKRIKHIN has 4 executives leading key functions including technology, operations, strategy, and sales.
Driven by a commitment to accessible healthcare, AKRIKHIN is dedicated to producing effective, affordable, and high-quality medications, serving patients and healthcare professionals with a diverse portfolio of over 200 socially significant pharmaceutical products.
Driven by a commitment to accessible healthcare, AKRIKHIN is dedicated to producing effective, affordable, and high-quality medications, serving patients and healthcare professionals with a diverse portfolio of over 200 socially significant pharmaceutical products.
Leadership Roles at AKRIKHIN
Konstantin Paramonov - Head Chief Operating Officer, Production Site
Konstantin Paramonov, the Head Chief Operating Officer, Production Site at AKRIKHIN, oversees all manufacturing operations and site management. Paramonov drives operational excellence, ensuring the efficient and high-quality production of AKRIKHIN's diverse portfolio of over 200 socially significant pharmaceutical products. This critical role involves managing production schedules, optimizing resource allocation, and maintaining strict adherence to international GMP standards across all manufacturing stages. By focusing on process improvement and supply chain efficiency, Konstantin Paramonov directly supports the company's mission to deliver effective and affordable medications. The Head Chief Operating Officer, Production Site ensures that production capacity aligns with market demand, contributing significantly to the reliable supply of prescription and over-the-counter drugs to healthcare professionals and patients.
Denis Chetverikov - President
Denis Chetverikov, the President at AKRIKHIN, sets the overarching strategic direction and vision for the company. Chetverikov guides AKRIKHIN's commitment to producing effective, affordable, and high-quality medications, overseeing the expansion of its diverse portfolio of over 200 socially significant pharmaceutical products. This executive leadership position involves fostering a culture of innovation, driving investment in research and development, and ensuring adherence to international GMP standards. By championing strategic initiatives, Denis Chetverikov strengthens AKRIKHIN's market position and its ability to serve healthcare professionals and patients with reliable medical treatments. The President's focus is on sustainable growth and enhancing the company's impact in the pharmaceutical sector, ensuring long-term success and accessibility of essential medicines.
Alexei Terentiev - Chief Information Officer
Alexei Terentiev, the Chief Information Officer at AKRIKHIN, directs the company's technology strategy and digital transformation initiatives. Overseeing all IT infrastructure and operations, Terentiev ensures the seamless integration of advanced technological solutions across the organization. This leadership role involves managing data security, optimizing information systems, and driving innovation in digital platforms to support AKRIKHIN's research and development efforts and production processes. By implementing robust IT frameworks, Alexei Terentiev enhances operational efficiency and supports the company's adherence to international GMP standards. The Chief Information Officer's focus remains on leveraging technology to improve accessibility and quality of AKRIKHIN's diverse pharmaceutical portfolio, ensuring reliable medical treatments for a wide range of clients.
Belyakova Tamara - Национальный менеджер по розничным продажам
Belyakova Tamara, the Национального менеджер по розничным продажам at AKRIKHIN, directs national retail sales strategies and execution. Tamara drives the commercial success of AKRIKHIN's extensive portfolio of over 200 socially significant pharmaceutical products within the retail sector. This role involves managing relationships with key retail partners, optimizing product placement, and implementing effective sales campaigns to ensure broad accessibility of prescription and over-the-counter drugs. By focusing on market penetration and consumer engagement, Belyakova Tamara significantly contributes to the company's revenue growth and its mission to provide affordable, high-quality medications. The Национального менеджер по розничным продажам ensures that AKRIKHIN's offerings reach patients effectively across Russia.
Explore Leadership Teams in Manufacturing
Bristol-Myers Squibb operates as a global biopharmaceutical organization dedicated to discovering, developing, and manufacturing prescription medications that address serious patient needs across multiple therapeutic domains. The company's scientific expertise spans oncology, cardiovascular disease, immunoscience, and virology, with particular depth in treating complex conditions including HIV and cancer. Through sustained investment in research and development, the organization has built a comprehensive medication portfolio that combines innovative cancer immunotherapies, anticoagulant therapies, and treatments for chronic viral infections. The company's operational footprint extends across major markets worldwide, enabling efficient distribution and patient access to its therapeutic solutions. Bristol-Myers Squibb pursues a collaborative approach to medical innovation, actively engaging in research partnerships and strategic alliances that accelerate the development of new treatment options. This commitment to external collaboration complements the organization's internal capabilities, creating a dynamic environment where scientific breakthroughs can translate into meaningful therapeutic advances. Bristol-Myers Squibb's medication portfolio reflects decades of pharmaceutical expertise and a strategic focus on disease areas where unmet medical needs remain significant.
Company Leadership BT
DG
KK
Founded in 1958 and headquartered in Chatswood, Australia, iNova Pharmaceuticals is an international organization that develops, markets, and sells a wide-range of prescription medicines and non-prescription consumer health products across Asia, Australia and New Zealand, and Africa.
Company Leadership JR
SE
AJ
Монос групп is a diversified company engaged in production, export, and import activities. They offer various services and manage projects while emphasizing social responsibility. The company also focuses on human resources, providing training and job opportunities. Their target clients include businesses and organizations seeking reliable partners in manufacturing and service sectors.
Company Leadership MN
SK
ImmunityBio is a vertically-integrated biotechnology company developing next-generation therapies and vaccines that bolster the natural immune system to defeat cancers and infectious diseases. The Companys range of immunotherapy and cell therapy platforms, alone and together, act to drive and sustain an immune response with the goal of creating durable and safe protection against disease. Designated an FDA Breakthrough Therapy, ANKTIVA is the first FDA-approved immunotherapy for non-muscle invasive bladder cancer CIS that activates natural killer cells, T cells, and memory T cells for a long-duration response. The Company is applying its science and platforms to treating cancers, including the development of potential cancer vaccines, as well as developing immunotherapies and cell therapies that we believe sharply reduce or eliminate the need for standard high-dose chemotherapy. These platforms and their associated product candidates are designed to be more effective, accessible, and easily administered than current standards of care in oncology and infectious diseases.
Company Leadership FJ
Frequently Asked Questions Regarding AKRIKHIN Top Executives and Leadership Team
Unlock more people and company data
